The Times Australia

Small Business Marketing
The Times

PR Newswire

Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE

SYDNEY, April 19, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that it has entered into a worldwide exclusive licensing agreement and a master services agreement with Evotec SE (FRA: EVT), a leading European drug discovery and development company, for...

Read more: Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor,...

Popular

How to use CBD oils to achieve the best results? Here are our suggestions

CBD oils have a positive influence on the human body. No wonder that more and more people are using this unique remedy. However, the key to achieving the best results...

The Lowdown on Cat Curfews

CAT CURFEWS AND HELPING YOUR CAT TO COPE Australia has one of the highest rates of pet ownership in the world, with over a quarter of Australian households owning a...

Sigrid Thornton to receive Walk of Fame honour at Slant premiere

Australian screen royalty, Sigrid Thornton will be inducted to the Australian Film Walk of Fame outside the historic Ritz Theatre in Randwick when she attends the Sydney Premiere of her...

Tomorrow Business Growth